Stannard, Kimberley A <br/><br/>
Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model.  [electronic resource] 

 -  Cancer letters  Dec 2010 
 - 95-110 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2010.08.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blotting, Western<br/>CD8-Positive T-Lymphocytes--immunology<br/>Cancer Vaccines--administration & dosage<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Crystallography, X-Ray<br/>Cytotoxicity, Immunologic--drug effects<br/>Disaccharides--chemistry<br/>Female<br/>Galectin 1--chemistry<br/>Galectin 3--chemistry<br/>Galectins--chemistry<br/>Humans<br/>Immunity--drug effects<br/>Immunotherapy--methods<br/>Mammary Neoplasms, Experimental--immunology<br/>Mice<br/>Mice, Inbred Strains<br/>Models, Molecular<br/>Protein Binding<br/>Thiogalactosides--chemistry<br/>Tumor Burden--drug effects